Yeollim Partners

Yeollim Partners is a South Korean venture capital firm that specializes in investments within the life sciences, biotechnology, and healthcare sectors. Established in 2019, the firm focuses on identifying and supporting early-to-growth stage companies with innovative technologies in drug discovery, medical devices, and digital health. The firm is led by experienced investment professionals with deep roots in the Korean bio-industry, providing strategic guidance alongside capital. Yeollim Partners is known for its active role in the South Korean biotech ecosystem, participating in significant funding rounds for prominent startups. Its portfolio includes a diverse range of companies working on long-acting injectables, antibody-drug conjugates, and AI-driven drug discovery. By bridging the gap between capital and scientific innovation, Yeollim Partners aims to accelerate the development of next-generation medical solutions.